Sensei Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary

Faeth Therapeutics,

10/05/2022 20:50

* Sensei Biotherapeutics Inc  SNSE.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 35 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Sensei Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 40 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sensei Biotherapeutics Inc shares had fallen by 33.8% this
quarter and lost 73.6% so far this year.
    * The company reported a quarterly loss of $12.41 million.
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 07:49 p.m.  ​All
figures in US dollars unless otherwise stated